Premium
OUTCOME OF LARGE B‐CELL LYMPHOMA PATIENTS FAILING CD19 TARGETED CAR‐T THERAPY
Author(s) -
Kuhnl A.,
Kirkwood A. A.,
O'Reilly M.,
Sanderson R.,
Tholouli E.,
Patel A.,
Besley C.,
Iyengar S.,
Jones C.,
Latif A.L.,
Norman J.,
Osborne W.,
Collins G.,
McMillan A.,
Ardeshna K.,
Chaganti S.,
Menne T.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.87_2879
Subject(s) - medicine , lenalidomide , refractory (planetary science) , cytokine release syndrome , gastroenterology , lymphoma , car t cell therapy , oncology , surgery , immunotherapy , chimeric antigen receptor , cancer , multiple myeloma , physics , astrobiology